We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Ve Bionic Etf | LSE:CYBG | London | Exchange Traded Fund |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 17.308 | 17.098 | 17.29 | 0 | 10:56:27 |
From May 2019 to May 2024
TIDMCYBG
RNS Number : 1595B
J.P. Morgan Securities Australia
18 September 2018
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
Hot Features
Premium
1. KEY INFORMATION
(a) Full name of discloser: J.P. Morgan Securities Australia Limited
(b) Owner or controller of interests and short positions disclosed, if N/A
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust,
the trustee(s),
settlor and beneficiaries must be named.
-----------------------------------------
(c) Name of offeror/offeree in relation to whose relevant securities this CYBG plc
form relates:
Use a separate form for each offeror/offeree
-----------------------------------------
(d) If an exempt fund manager connected with an offeror/offeree, state No
this and specify identity
of offeror/offeree:
-----------------------------------------
(e) Date position held/dealing undertaken: 17 September 2018
For an opening position disclosure, state the latest practicable date
prior to the disclosure
-----------------------------------------
(f) In addition to the company in 1(c) above, is the discloser making No
disclosures in respect
of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
-----------------------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 10p ordinary
Interests Short positions
--------------------- ---------------------
Number % Number %
------------ ------- ------------ -------
(1) Relevant securities owned and/or controlled: 5,201,100 0.59 2,140,903 0.24
------------ ------- ------------ -------
(2) Cash-settled derivatives: 2,019,599 0.23 4,336,989 0.49
------------ ------- ------------ -------
(3) Stock-settled derivatives (including options) and agreements to
purchase/sell: - - 200,000 0.02
------------ ------- ------------ -------
TOTAL: 7,220,699 0.82 6,677,892 0.75
------------ ------- ------------ -------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
10p ordinary
Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit (AUD)
CDI Purchase 187 6.0200
200 6.0400
199 6.0450
562 6.0500
230 6.0550
7,880 6.0616
1,434 6.0650
1,919 6.0675
2,031 6.0700
4,119 6.0750
3,327 6.0800
1,935 6.0816
3,326 6.0829
4,567 6.0850
396 6.0900
2,216 6.1000
Sale 4,171 6.0246
996 6.0433
115 6.0550
1,434 6.0650
2,247 6.0700
3,306 6.0720
1,159 6.0743
2,631 6.0750
8,500 6.0796
1,277 6.0850
7,020 6.0866
4,204 6.1000
-------------- --------------------- ---------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit (AUD)
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
CDI Equity Swaps Long 1,159 6.0743
7,020 6.0860
Short 7,880 6.0622
2,867 6.0822
459 6.0905
-------------------- ----------------------- ----------------------- ---------------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit (AUD) American, received per
option varying etc. option European unit
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(AUD)
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the person making the disclosure and any party to the offer or
any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person
making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 18 September 2018
Contact name: Alwyn Basch
------------------
Telephone number: 0207 742 7407
------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure: J.P. Morgan Securities Australia Limited
Name of offeror/offeree in relation to whose relevant securities the CYBG plc
disclosure relates:
-----------------------------------------
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of Product Written or Number of Exercise price Type Expiry date
relevant description purchased securities to per unit (AUD) e.g. American,
security e.g. call which option European etc.
option or derivative
relates
CDI Put Option Purchased 200,000 5.50 American 25/10/2018
---------------- ----------------- --------------- --------------- --------------- ------------
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the
interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RETBSGDCUGBBGII
(END) Dow Jones Newswires
September 18, 2018 10:07 ET (14:07 GMT)
1 Year Ve Bionic Etf Chart |
1 Month Ve Bionic Etf Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
